Innate Pharma SA
F:IDD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
F:IDD
|
FR |
|
Schibsted ASA
OSE:SCHA
|
NO |
|
Alligator Energy Ltd
ASX:AGE
|
AU |
|
C
|
Capital Trust Ltd
NSE:CAPTRUST
|
IN |
|
C
|
CIE Automotive SA
F:CAD
|
ES |
|
A
|
Aurora Design PCL
SET:AURA
|
TH |
|
G
|
GSW Immobilien AG
F:GIB
|
DE |
|
T
|
Thai Textile Industry PCL
SET:TTI
|
TH |
|
E
|
Etoiles Capital Group Co Ltd
NASDAQ:EFTY
|
HK |
Wall St Price Targets
IDD Price Targets Summary
Innate Pharma SA
According to Wall Street analysts, the average 1-year price target for IDD is 5.323 EUR with a low forecast of 4.433 EUR and a high forecast of 6.35 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDD's stock price target?
Price Target
5.323
EUR
According to Wall Street analysts, the average 1-year price target for IDD is 5.323 EUR with a low forecast of 4.433 EUR and a high forecast of 6.35 EUR.
What is the Revenue forecast for Innate Pharma SA?
Projected CAGR
92%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 7 years is 92%.
What is the Gross Profit forecast for Innate Pharma SA?
Projected CAGR
1 086%
The compound annual growth rate for Gross Profit over the next 3 years is 1 086%.
